A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyond weight loss. Why do GLP-1 weight-loss drugs seem to quiet cravings in ways that go beyond simple appetite suppression? A new NIH-funded study suggests the answer may lie deep within the […]This is a curated summary.